Table 11.
Disease
type |
Inhibitor | Target | Administration | Phase | Study number |
---|---|---|---|---|---|
cHE | Delgocitinib | PanJAK | Topical | Phase II | NCT03683719 |
Delgocitinib | PanJAK | Topical | Phase II | NCT02664805 |
Disease
type |
Inhibitor | Target | Administration | Phase | Study number |
---|---|---|---|---|---|
cHE | Delgocitinib | PanJAK | Topical | Phase II | NCT03683719 |
Delgocitinib | PanJAK | Topical | Phase II | NCT02664805 |